Montelukast oral film - IntelGenx

Drug Profile

Montelukast oral film - IntelGenx

Alternative Names: INT 0043/2015; INT0043; Montelukast VersaFilm

Latest Information Update: 29 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator IntelGenx Corp.
  • Class Acetates; Antiasthmatics; Antidementias; Neuroprotectants; Quinolines; Small molecules
  • Mechanism of Action Leukotriene D4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes - Alzheimer's disease; Mild cognitive impairment

Highest Development Phases

  • Phase II Alzheimer's disease
  • Phase I Mild cognitive impairment

Most Recent Events

  • 24 Jan 2018 Phase-II clinical trials in Alzheimer's disease (In the elderly, In adults) in Canada (PO) (NCT03402503)
  • 15 Dec 2017 IntelGenx plans a phase IIa trial for Alzheimer's disease (In adults, In the elderly) in Canada in the first quarter of 2018
  • 15 Dec 2017 Health Canada approves Clinical Trial Application for initiation of a phase IIa trial in Alzheimer's disease
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top